Compare Novartis AG (NVS) vs Victoria's Secret & Co (VSXY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novartis AG vs Victoria's Secret & Co — how do they compare? Novartis AG trades at $152.33 (market cap $295.37B), while Victoria's Secret & Co trades at $94 (market cap $7.48B). The key difference: Novartis AG is far larger — about 39.5× Victoria's Secret & Co's market cap, and Novartis AG pays a 3.07% dividend while Victoria's Secret & Co pays none. Which is the better fit depends on your goals.
| NVS | VSXY | |
|---|---|---|
Market Cap | $295.37B | $7.48B |
Sector | Health | Consumer Cyclical |
52-Week High | $168.62 | $99.97 |
52-Week Low | $119.31 | $21.34 |
Enterprise Value | $336.69B | $10.13B |
Dividend Yield | 3.07% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →About Victoria's Secret & Co
Victoria's Secret & Co is a specialty retailer of lingerie, pajamas, and beauty products with prestige fragrances and body care. It serves customers at its Lingerie and Beauty stores around the globe and online enabling them to shop the brand anywhere and anytime.
Read more on VSXY →
